No. Cholesterol itself is not bad for you. It is an essential substance the body uses to build cell membranes, produce steroid hormones, make bile acids and support other normal functions. The cardiovascular concern is not cholesterol's existence, but prolonged exposure to excessive numbers of atherogenic lipoprotein particles that can enter artery walls and contribute to plaque formation. LDL cholesterol, non-HDL cholesterol, apolipoprotein B (ApoB) and lipoprotein(a) provide different information about this risk. The 2026 American College of Cardiology and American Heart Association dyslipidemia guideline emphasizes reducing lifetime exposure to harmful lipoprotein levels while considering metabolic health, genetics, other cardiovascular risk factors and appropriate treatment. A strong cholesterol-support strategy therefore begins with understanding the lipid pattern rather than trying to eliminate cholesterol from the body.

Cholesterol has acquired a negative reputation because elevated blood cholesterol is associated with heart disease and stroke. This has led to confusion about whether cholesterol is harmful, whether the body needs it and whether eating foods that contain cholesterol directly causes arterial plaque.

The answer requires an important distinction. Cholesterol is necessary for life, but the way it travels through the bloodstream influences cardiovascular risk. The liver produces cholesterol, and the body moves it between organs using specialized particles called lipoproteins. Some of these particles can contribute to atherosclerosis when their concentrations remain elevated over time.

That is why a person can have too much LDL cholesterol circulating in the blood without having too much cholesterol inside every cell. It also explains why cholesterol-lowering treatment does not mean depriving the body of a substance it needs to function.

The goal is not to remove all cholesterol. It is to maintain appropriate lipid metabolism while reducing the exposure of artery walls to particles that can contribute to cardiovascular disease.

A better approach to cholesterol asks what is increasing atherosclerotic risk, which factors can be improved and how nutrition, lifestyle, targeted supplements and medical care can work together to lower that risk.

What Is Cholesterol, and Why Does the Body Need It?

Cholesterol is a waxy, fat-like substance belonging to a class of compounds called sterols. It is present in cell membranes throughout the body and participates in several essential physiological processes.

The body can make the cholesterol it needs, particularly through synthesis in the liver and other tissues. Dietary cholesterol contributes an additional source, but consuming cholesterol is not necessary to meet a specific essential nutrient requirement.

Cell Membranes

Cholesterol is an important structural component of animal cell membranes. It helps regulate membrane properties, including fluidity and organization, and supports the normal function of proteins embedded within those membranes.

Without cholesterol, cells could not maintain the same normal structure and signaling processes.

Hormone Production

Cholesterol is a precursor for steroid hormones, including cortisol, aldosterone, estrogen, progesterone and testosterone.

These hormones participate in metabolism, fluid regulation, reproduction and many other functions.

However, this does not mean that having high LDL cholesterol improves hormone production. The body regulates hormone synthesis through specialized physiological systems.

Bile Acid Production

The liver converts cholesterol into bile acids that help the digestive system process and absorb dietary fats.

Bile acids also participate in the absorption of fat-soluble nutrients.

This connection explains why cholesterol metabolism and digestive function are related, but it does not mean high LDL cholesterol is usually caused by poor bile flow or a congested gallbladder.

Vitamin D Synthesis

A cholesterol-related compound in the skin serves as a precursor in vitamin D synthesis when exposed to ultraviolet B radiation.

However, having elevated blood LDL cholesterol does not guarantee adequate vitamin D status.

Brain and Nervous-System Function

Cholesterol is an important structural component of nervous tissue and myelin.

The brain regulates much of its own cholesterol metabolism, and brain cholesterol physiology is not equivalent to the LDL cholesterol measured in routine blood tests.

Cholesterol is essential to normal biology. The cardiovascular problem arises when certain cholesterol-carrying particles circulate at levels that increase arterial plaque risk.

What Is the Difference Between Cholesterol and Lipoproteins?

Cholesterol does not dissolve freely in the water-based portion of blood. It travels in particles called lipoproteins, which contain combinations of cholesterol, triglycerides, phospholipids and specialized proteins.

Different lipoproteins perform different transport functions.

Understanding this distinction is central to understanding cardiovascular risk because atherosclerosis is influenced by which particles are circulating, how many are present and how long arteries are exposed to them.

LDL Particles

Low-density lipoprotein particles carry cholesterol through the bloodstream. They are important in lipid transport, but elevated numbers increase opportunities for particles to enter the arterial wall.

HDL Particles

High-density lipoproteins participate in cholesterol transport and other physiological processes, including pathways involved in moving cholesterol from peripheral tissues toward the liver.

Triglyceride-Rich Lipoproteins

Very-low-density lipoproteins and remnant particles transport triglycerides and cholesterol. Some of these particles also contribute to atherosclerotic risk.

Lipoprotein(a)

Lipoprotein(a), abbreviated Lp(a), is an LDL-like particle containing an additional protein called apolipoprotein(a). Its concentration is strongly influenced by inherited factors.

Elevated Lp(a) can increase cardiovascular risk even when other lipid measurements appear relatively favorable.

These differences explain why total cholesterol alone does not fully describe cardiovascular health.

Is LDL Cholesterol Really Bad?

LDL cholesterol is often called bad cholesterol, but that name is a simplification.

LDL particles perform a normal transport function. The problem is that too many circulating atherogenic particles, particularly over many years, increase the probability of cholesterol-containing material accumulating inside artery walls.

How LDL Contributes to Plaque Formation

LDL particles can enter the arterial wall and become retained within it. This retention can trigger biological processes involving modified lipoproteins, immune cells and inflammation.

Over time, cholesterol-rich material and other components can accumulate, contributing to an atherosclerotic plaque.

As plaque develops, it may change the artery's structure and narrow the channel through which blood flows.

Why Long-Term LDL Exposure Matters

Cardiovascular risk depends partly on both the concentration of atherogenic lipoproteins and the duration of exposure.

Someone with markedly elevated LDL from a young age may accumulate substantially greater lifetime exposure than a person whose LDL becomes mildly elevated much later.

This is one reason the 2026 dyslipidemia guideline emphasizes earlier identification and treatment of significant lipid abnormalities.

Can LDL Be Too High Even When Someone Feels Healthy?

Yes. Elevated LDL cholesterol generally produces no recognizable symptoms.

A person may have good exercise tolerance and feel physically well while atherosclerosis develops gradually.

Symptoms should therefore not be used to determine whether LDL levels are appropriate.

Does Lowering LDL Reduce Cardiovascular Risk?

Yes. Extensive clinical evidence demonstrates that lowering LDL cholesterol through effective interventions reduces atherosclerotic cardiovascular events in appropriate populations.

That does not mean every person requires identical treatment. The appropriate LDL goal and treatment intensity depend on risk, age, existing cardiovascular disease and other factors.

Is HDL Cholesterol Always Good?

HDL cholesterol is often called good cholesterol because HDL particles participate in cholesterol transport and several other biological processes.

Higher HDL cholesterol has historically been associated with lower cardiovascular risk in population studies.

However, the relationship is more complicated than the familiar good-versus-bad description suggests.

Why HDL Is Different From LDL

HDL and LDL are different particles with different physiological functions.

HDL contributes to pathways involved in cholesterol handling, but its concentration does not directly measure how efficiently every protective function is operating.

Does Raising HDL Prevent Heart Attacks?

Not necessarily. Treatments that increase HDL cholesterol have not consistently reduced cardiovascular events simply because HDL levels rose.

This means that raising HDL should not replace efforts to lower excessive LDL, manage blood pressure, avoid smoking and address diabetes.

What if HDL Is Low?

Low HDL can occur alongside high triglycerides, insulin resistance and other metabolic risk factors.

The most useful approach is often improving overall metabolic and cardiovascular health rather than choosing a supplement solely to raise HDL.

LDL reduction is an established treatment target. Increasing HDL concentration by itself is not an equivalent, proven strategy for preventing cardiovascular events.

What Are Triglycerides, and Why Do They Matter?

Triglycerides are the main form of fat stored in the body and an important source of energy.

They are also transported through the bloodstream in specialized lipoproteins.

Elevated triglycerides often occur alongside metabolic conditions that increase cardiovascular risk.

Common Contributors to Elevated Triglycerides

Possible contributors include:

• Insulin resistance and diabetes
• Excess visceral fat
• High alcohol intake
• Excess energy intake
• Certain medications
• Some kidney, thyroid and metabolic conditions
• Inherited lipid disorders

Why Triglyceride-Rich Particles Matter

Some triglyceride-rich particles and their remnants carry cholesterol that can contribute to atherosclerosis.

Therefore, lipid-related cardiovascular risk cannot always be explained by LDL cholesterol alone.

Very High Triglycerides and Pancreatitis

Very high triglyceride concentrations can also increase the risk of acute pancreatitis, a serious inflammatory condition of the pancreas.

The 2026 guideline highlights particular concern when triglycerides reach 1,000 mg/dL or higher, although pancreatitis risk can become important at lower severe elevations as well.

Do Omega-3 Supplements Help?

EPA and DHA omega-3 fatty acids can reduce triglyceride levels, particularly at therapeutic doses.

However, prescription omega-3 products used for specific clinical indications are not interchangeable with ordinary over-the-counter fish oil.

Likewise, lowering triglycerides does not automatically establish that every omega-3 product prevents heart attacks or strokes.

What Is Non-HDL Cholesterol?

Non-HDL cholesterol is calculated by subtracting HDL cholesterol from total cholesterol.

It includes the cholesterol carried by LDL and other potentially atherogenic lipoproteins.

This can provide a broader view of cholesterol-related risk than LDL cholesterol alone, particularly when triglyceride-rich particles are elevated.

Why Is Non-HDL Useful?

A standard lipid panel provides the information needed to calculate non-HDL cholesterol.

Because non-HDL includes several types of atherogenic particles, it may capture cholesterol exposure not fully reflected by LDL cholesterol.

Does Non-HDL Replace LDL?

No. The two measures are complementary.

The 2026 dyslipidemia guideline recognizes LDL and non-HDL cholesterol as treatment goals, with targets depending on cardiovascular risk.

What Is ApoB, and Why Is It Important?

Apolipoprotein B, or ApoB, is a structural protein found on the major atherogenic lipoprotein particles.

Each LDL particle contains one ApoB molecule, and other atherogenic particles also carry ApoB.

Measuring ApoB therefore provides information about the number of circulating atherogenic particles rather than only the amount of cholesterol within them.

Why Can LDL and ApoB Give Different Information?

Two individuals can have similar LDL cholesterol values but different concentrations of LDL and other ApoB-containing particles.

One person may have more particles carrying less cholesterol per particle, while another may have fewer particles carrying more cholesterol each.

That difference can matter for estimating atherosclerotic risk.

Who May Benefit From ApoB Testing?

The 2026 ACC/AHA guideline identifies ApoB testing as useful in selected situations, particularly when triglycerides are elevated, diabetes is present or LDL cholesterol has been substantially lowered but residual lipid-related risk remains uncertain.

ApoB may also help clarify certain complex lipid disorders.

Does Everyone Need ApoB Testing?

Not necessarily. A standard lipid panel remains an appropriate starting point for many adults.

ApoB provides additional information when it may affect cardiovascular risk assessment or treatment decisions.

What Is Lipoprotein(a), and Is It Dangerous?

Lipoprotein(a), abbreviated Lp(a), is a largely inherited lipoprotein associated with an increased risk of atherosclerotic cardiovascular disease.

Unlike many other lipid-related markers, Lp(a) usually changes relatively little with ordinary diet, exercise or weight loss.

Why Does Lp(a) Matter?

Elevated Lp(a) can increase cardiovascular risk even when LDL cholesterol appears reasonably controlled.

It may help explain why some individuals develop premature cardiovascular disease despite otherwise favorable habits.

Should Lp(a) Be Tested?

The 2026 dyslipidemia guideline recommends measuring Lp(a) at least once in adulthood.

It identifies values of 125 nmol/L or higher, approximately corresponding to 50 mg/dL, as an important risk-enhancing threshold.

Results reported in nmol/L and mg/dL are not exactly interchangeable because the relationship depends on particle characteristics. Laboratories and clinicians should interpret the reported units appropriately.

Can Supplements Lower Lp(a)?

Ordinary supplements and lifestyle changes have not been established as reliable methods for substantially lowering inherited Lp(a) or eliminating the risk associated with it.

When Lp(a) is elevated, the emphasis is on managing modifiable risks, including LDL cholesterol, blood pressure, diabetes and smoking exposure.

How Does Cholesterol Contribute to Atherosclerosis?

Atherosclerosis is a chronic process in which cholesterol-containing particles, immune cells, connective tissue and other material accumulate within artery walls.

It is not simply dietary fat sticking to the inside of a blood vessel.

Particle Entry and Retention

ApoB-containing lipoproteins can enter and become retained in the arterial wall.

That retention contributes to inflammatory and cellular responses involved in the early development of plaque.

Plaque Development

Over time, atherosclerotic plaques may become more complex, containing cholesterol-rich material, fibrous tissue and varying degrees of calcium.

Some plaques gradually narrow arteries and limit blood flow, particularly during exertion.

Plaque Rupture and Blood Clots

Some plaques can become disrupted, allowing a blood clot to form at the site.

A sudden blockage in a coronary artery may cause a heart attack, while interruption of blood flow in an artery supplying the brain may cause an ischemic stroke.

Is Plaque Caused by Cholesterol Alone?

No. Atherosclerosis involves several interacting processes and risk factors.

Elevated LDL and other atherogenic particles are central contributors, while smoking, hypertension, diabetes, kidney disease, genetics and age can influence disease development and complications.

However, complexity should not be used to dismiss the causal importance of atherogenic lipoproteins.

The strongest prevention strategy reduces long-term exposure to atherogenic particles while addressing the other conditions that damage blood vessels and increase cardiovascular risk.

Is Dietary Cholesterol the Same as Blood Cholesterol?

No. Dietary cholesterol is cholesterol consumed in food, while blood cholesterol represents cholesterol transported in circulating lipoproteins.

The two are related through digestion, absorption and the body's regulation of cholesterol production and removal, but they are not identical.

Where Does Dietary Cholesterol Come From?

Dietary cholesterol is present in animal-derived foods, including eggs, meat, poultry, seafood and dairy products.

Plant foods do not naturally contain cholesterol in the same way animal-derived foods do.

Does Eating Cholesterol Automatically Raise LDL?

Dietary cholesterol can influence blood cholesterol, but the response varies among individuals.

For many people, saturated fat intake and the overall dietary pattern have more important implications for LDL cholesterol than dietary cholesterol alone.

What Does the 2026 AHA Dietary Guidance Say?

The American Heart Association's 2026 dietary guidance emphasizes overall dietary patterns and the quality of dietary fats.

For most individuals, dietary cholesterol is no longer the primary target for reducing cardiovascular risk.

This does not mean unlimited consumption of cholesterol-rich foods is appropriate or that people with certain lipid disorders should ignore dietary advice.

Can Eggs Fit Into a Heart-Healthy Diet?

Yes, for many individuals, eggs can fit within an appropriate heart-healthy dietary pattern.

However, portion size, accompanying foods, total saturated fat intake, individual LDL response and overall cardiovascular risk matter.

Someone with familial hypercholesterolemia or substantially elevated LDL may require more individualized dietary guidance.

Why Does Saturated Fat Matter More Than Simply Avoiding Cholesterol?

Saturated fat can raise LDL cholesterol, partly through effects on how the liver regulates circulating LDL particles.

Clinical evidence supports replacing some saturated fat with unsaturated fat rather than simply removing all dietary fat.

Common Sources of Saturated Fat

Foods that can contribute substantial saturated fat include:

• Butter, cream and high-fat dairy products
• Fatty and processed meats
• Coconut oil and palm oil
• Some pastries, desserts and fried foods
• Certain packaged foods made with saturated-fat-rich ingredients

Choose Better Fat Substitutions

Olive oil, nuts, seeds, avocado and appropriate vegetable oils provide unsaturated fats that can replace some saturated-fat-rich choices.

Fish can also contribute to a heart-healthy eating pattern.

The key word is replace. Simply adding large amounts of oil or nuts without considering overall energy intake may not produce the intended metabolic benefits.

Are All Animal Foods Equally Harmful?

No. Animal-derived foods differ considerably in saturated fat content, nutrient composition and degree of processing.

Fish, seafood, low-fat dairy foods and lean poultry can fit within evidence-based cardiovascular eating patterns.

The overall diet matters more than categorizing every animal-derived food as equally harmful.

What About Trans Fats?

Industrially produced trans fats adversely affect blood lipids and cardiovascular risk.

They should be minimized or avoided as part of a heart-healthy dietary pattern.

What Role Does the Liver Play in Cholesterol Regulation?

The liver is central to cholesterol synthesis, lipoprotein production, uptake and clearance.

It also converts cholesterol into bile acids, which participate in fat digestion and cholesterol metabolism.

Because these functions are connected, liver physiology belongs in a comprehensive explanation of cardiovascular health.

Cholesterol Production

The body synthesizes cholesterol through regulated metabolic pathways.

One important enzyme in cholesterol synthesis is HMG-CoA reductase, which is targeted by statin medications.

LDL Clearance

The liver removes LDL particles from the circulation through receptors and other processes.

Genetic differences, metabolic conditions and medications can influence these pathways.

Bile Acids and Cholesterol Elimination

Bile acids are produced from cholesterol and secreted into the intestine, where most are normally reabsorbed and recycled.

Some cholesterol and bile-related material ultimately leaves the body through stool.

Viscous soluble fiber can influence bile-acid handling, which is one mechanism behind its LDL-lowering effect.

Is High Cholesterol Caused by a Congested Liver?

Not generally. Elevated LDL cholesterol may arise from genetics, saturated fat intake, metabolic disorders, thyroid problems, kidney disease or medication effects.

Terms such as liver congestion and gallbladder toxicity do not provide established explanations for most cases of elevated LDL.

Similarly, low stomach acid and routine colon cleansing are not established primary treatments for atherosclerotic cardiovascular risk.

Can Genetics Cause High Cholesterol Despite a Healthy Diet?

Yes. Genetics can strongly influence lipid concentrations and cardiovascular risk.

Some individuals have substantially elevated LDL cholesterol despite maintaining nutritious diets, exercising regularly and having a healthy body composition.

Familial Hypercholesterolemia

Familial hypercholesterolemia, often abbreviated FH, is an inherited condition associated with high LDL cholesterol from an early age.

Because exposure begins early, affected individuals can develop premature atherosclerotic cardiovascular disease without appropriate treatment.

Why Family History Matters

A family history of premature heart attack or stroke may indicate inherited susceptibility, even when routine testing appears relatively reassuring.

Family history can influence the need for further lipid testing and earlier treatment.

Does Lifestyle Still Matter?

Yes. Nutrition, activity, nicotine avoidance and other healthy habits remain important.

However, inherited lipid disorders may require medication to reduce LDL sufficiently.

Someone with FH should not be expected to correct a genetically driven LDL elevation through digestive cleansing or supplements alone.

What Changed in the 2026 ACC/AHA Dyslipidemia Guideline?

The 2026 guideline replaces the 2018 cholesterol management guideline and broadens the emphasis from cholesterol alone to dyslipidemia, including atherogenic lipoproteins, triglycerides and inherited Lp(a) risk.

It recognizes that appropriate treatment depends on long-term exposure, overall cardiovascular risk and the response to interventions.

Earlier Prevention

The guideline emphasizes addressing significant lipid abnormalities earlier to reduce lifetime exposure to atherogenic particles.

This is especially important for familial hypercholesterolemia, LDL cholesterol of 160 mg/dL or higher in relevant younger adults, and strong family histories of premature disease.

PREVENT Risk Assessment

For appropriate adults aged 30–79 without established atherosclerotic cardiovascular disease, the guideline uses the American Heart Association PREVENT-ASCVD equations to estimate 10-year risk and help guide primary-prevention treatment decisions.

These estimates are combined with clinical factors not fully captured by a calculator.

Risk-Based Medication Decisions

The guideline supports discussion of LDL-lowering medication in adults at borderline or intermediate estimated cardiovascular risk, using contemporary risk thresholds.

A 10-year PREVENT-ASCVD risk of approximately 3% to less than 5% represents a borderline-risk range where treatment may be considered. At 5% to less than 10%, LDL-lowering treatment should generally receive stronger consideration.

However, established cardiovascular disease, certain inherited lipid disorders and conditions such as diabetes or significant kidney disease may require separate treatment pathways rather than reliance on one calculated percentage.

LDL and Non-HDL Treatment Goals

The guideline restores explicit LDL and non-HDL cholesterol treatment goals, with more intensive targets for people at greater risk.

For example, it recommends an LDL goal below 55 mg/dL for people with very-high-risk established atherosclerotic cardiovascular disease.

Other individuals may have less intensive goals based on their risk profile.

More Attention to ApoB

ApoB testing can help identify residual lipoprotein-related risk, particularly when triglycerides are elevated, diabetes is present or LDL cholesterol has already been substantially reduced.

Lp(a) Testing at Least Once

The guideline recommends measuring Lp(a) at least once in adulthood to identify inherited cardiovascular risk that routine lipid testing may miss.

Selective Coronary Calcium Testing

Coronary artery calcium scoring may help refine cardiovascular risk in selected adults when the decision about lipid-lowering treatment remains uncertain.

It is not necessary for everyone and does not replace attention to major risk factors.

The central message is to reduce the right risk factors early enough, use more informative measurements when necessary and match treatment intensity to the individual's actual cardiovascular risk.

What Cholesterol Tests Should You Know?

A standard lipid panel is the usual starting point for understanding blood cholesterol and triglycerides.

Additional tests may help when risk is uncertain or the lipid pattern is complex.

Standard Lipid Panel

A typical lipid panel reports total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides.

Non-HDL cholesterol can be calculated by subtracting HDL from total cholesterol.

ApoB

ApoB testing can help estimate the number of atherogenic lipoprotein particles.

It may be especially useful when LDL cholesterol and other lipid-related indicators do not appear to tell the same story.

Lipoprotein(a)

Because Lp(a) is largely inherited and usually changes little with lifestyle, a single adult measurement can provide important long-term risk information.

Blood Glucose and HbA1c

Glucose testing may help identify diabetes or metabolic dysfunction that contributes to triglyceride abnormalities and cardiovascular risk.

Thyroid and Kidney Function

Hypothyroidism, kidney disease and certain other medical conditions can influence lipid levels.

Clinicians may investigate these causes when cholesterol is unusually elevated or the pattern suggests an underlying disorder.

Coronary Artery Calcium

A coronary artery calcium scan may help clarify the presence of calcified plaque in selected adults when the decision about preventive lipid-lowering treatment is uncertain.

Its usefulness depends on the person's age, existing disease and overall clinical circumstances.

Do You Need Every Test?

No. Testing should answer a specific question and help guide management.

The goal is not to obtain every possible cardiovascular marker but to identify the measurements that improve understanding of actual risk.

Can You Lower LDL Cholesterol Naturally?

Yes. Evidence-supported dietary and lifestyle changes can lower LDL cholesterol in many people.

However, the amount of improvement depends on the starting level, genetics, overall metabolic health and the intervention used.

Some people achieve substantial improvements through nutrition alone, while others need additional medical treatment.

Replace Some Saturated Fat With Unsaturated Fat

Reducing frequent sources of saturated fat and replacing them with appropriate unsaturated fats can improve LDL cholesterol.

Examples include using olive oil instead of butter and choosing nuts, seeds or other suitable foods in place of certain saturated-fat-rich snacks.

Increase Viscous Soluble Fiber

Viscous soluble fibers can help lower LDL through effects on bile-acid and cholesterol metabolism.

Useful food sources include oats, barley, beans, lentils and certain fruits.

Psyllium is another well-studied option when supplemental fiber is appropriate.

Consider Plant Sterols and Stanols

Plant sterols and stanols can reduce intestinal cholesterol absorption.

When consumed in appropriate amounts, they may modestly lower LDL cholesterol.

However, lowering LDL with a particular food component does not automatically establish a comparable reduction in cardiovascular events for that specific supplement.

Improve Overall Food Quality

A Mediterranean-style or DASH-style eating pattern provides a sustainable foundation for cardiovascular health.

These patterns emphasize vegetables, fruit, legumes, whole grains, nuts, seeds, unsaturated fats and suitable protein sources.

Address Excess Weight When Relevant

For people with excess body fat and metabolic dysfunction, sustainable weight management may improve triglycerides, blood sugar and other cardiovascular markers.

The effect on LDL varies, and weight reduction alone may not correct significant inherited LDL elevation.

Maintain Regular Physical Activity

Regular activity improves cardiovascular fitness and may benefit triglycerides, insulin sensitivity and overall metabolic health.

Exercise is valuable even when its direct LDL-lowering effect is modest.

Avoid Smoking and Nicotine Exposure

Smoking increases cardiovascular risk through several mechanisms beyond cholesterol.

Stopping smoking is an important part of comprehensive atherosclerosis prevention.

Improve Sleep and Manage Other Conditions

Sleep apnea, diabetes, thyroid disease and other medical conditions may influence cardiovascular risk or lipid patterns.

Addressing these problems helps create a more effective long-term plan.

Where Does Total Health Secrets Cholesterol Support Fit?

Total Health Secrets provides several products that can be considered within a cardiovascular nutritional-support program.

For cholesterol management, supplements are most useful when grouped according to the specific function they are intended to support, rather than treated as interchangeable heart-health products.

The strongest evidence for natural LDL reduction supports interventions such as viscous soluble fiber, plant sterols and replacing some saturated fat with unsaturated fat. Other products may offer antioxidant or broader cardiovascular nutritional support, but their roles should not be confused with established LDL-lowering treatments.

Cholesterol and Lipid Antioxidant Support — Deltanol

Deltanol from Premier Research Labs contains tocotrienols from the vitamin E family, derived from annatto.

Its current supplement facts identify 99 milligrams of tocotrienols from a DeltaGold ingredient containing predominantly delta-tocotrienols with a smaller gamma-tocotrienol component.

Tocotrienols have been studied for antioxidant activity and potential effects on lipid metabolism, making Deltanol relevant to a discussion of targeted lipid-related nutritional support.

However, the evidence is not sufficiently consistent to conclude that Deltanol reliably lowers LDL or ApoB to a clinically appropriate target, reverses coronary plaque or prevents heart attacks.

Laboratory findings and research involving isolated tocotrienols should not be treated as proof of clinical outcomes from the finished product.

Deltanol may fit as an additional nutritional option when appropriate, but it should not replace established LDL-lowering treatment in people at substantial cardiovascular risk.

Broad Botanical Cardiovascular Support — Cardio-ND

Cardio-ND from Premier Research Labs is a fermented botanical formula containing ingredients including hawthorn, green tea, turmeric, cinnamon, garlic and cayenne.

These ingredients have been investigated for various biological and cardiovascular effects, and the formula is marketed for broad heart and circulatory support.

However, the presence of potentially active botanicals does not establish that the finished product reduces LDL, ApoB, Lp(a) or atherosclerotic cardiovascular events.

Cardio-ND should therefore be viewed as a broad botanical-support option rather than a proven treatment for high cholesterol.

Cellular Energy Support — CoQ-10

CoQ-10 from Premier Research Labs provides 100 milligrams of coenzyme Q10, listed as ubiquinone, per capsule.

CoQ10 participates in mitochondrial energy production and normal cellular antioxidant function. It is present in tissues with substantial metabolic demands, including the heart.

CoQ10 can be considered for targeted cellular-energy nutritional support, but it is not an established LDL-lowering treatment and should not be presented as a substitute for statins or other indicated lipid therapies.

Research on CoQ10 for statin-associated muscle symptoms has produced mixed findings. The supplement may also interact with warfarin.

Additional Soluble Fiber Support — Galactan

Galactan from Premier Research Labs provides larch-derived arabinogalactan, a fermentable soluble fiber.

The current listing provides 6 grams of dietary fiber per two-tablespoon serving.

Galactan can contribute to overall fiber intake and provide substrates for intestinal microbial fermentation.

However, not all soluble fibers have the same LDL-lowering properties. The clinical evidence supporting viscous psyllium for cholesterol reduction should not automatically be attributed to larch arabinogalactan.

Galactan fits more appropriately as additional dietary fiber and digestive-support nutrition than as a proven treatment for elevated LDL cholesterol.

Some individuals may experience gas or bloating with fermentable fibers.

Plant-Based Nutritional Support — Premier Greens Powder

Premier Greens Powder</a contains plant-derived ingredients including organic barley grass, oat grass, kale, chlorella and other greens.

The formula may help complement a varied diet when vegetable intake is inconsistent.

However, it should not replace whole vegetables, legumes, fruit and other fiber-rich foods that contribute to an evidence-based heart-healthy dietary pattern.

The product is not an established treatment for elevated LDL, and claims about changing blood pH should not be used as evidence of cardiovascular protection.

Evidence-Informed Options Not Assigned to an Unverified THS Product

Some of the most useful nutrient-based strategies for LDL management involve ingredients or foods rather than a specific product listed in the current THS cardiovascular category.

These include:

• Psyllium: A viscous soluble fiber with clinical evidence for modest LDL reduction.
• Plant sterols and stanols: Compounds that reduce intestinal cholesterol absorption.
• Oats and barley: Whole-food sources of beta-glucan fiber.
• Legumes: Sources of fiber, plant protein and other nutrients that can help improve the overall eating pattern.
• Omega-3 fatty acids: Most relevant to triglyceride management, rather than serving as a primary LDL-lowering treatment.

These options can complement one another, but their effects differ. Choosing them according to the actual lipid problem is more useful than assuming every supplement marketed for heart health lowers LDL.

What About Red Yeast Rice?

Red yeast rice requires particular caution.

Some products contain monacolin K, a compound chemically identical to the prescription drug lovastatin.

Products containing meaningful amounts may lower LDL, but they can also produce statin-like adverse effects and drug interactions. Product potency varies, and contamination with citrinin has been reported.

Red yeast rice should not be treated as a harmless natural alternative to statin therapy or used without consideration of medical safety.

Do You Need Every Cholesterol Supplement?

No. A person with elevated LDL may benefit most from dietary fat changes, viscous soluble fiber and appropriate LDL-lowering therapy.

Someone with high triglycerides may need greater emphasis on insulin resistance, alcohol intake, overall food quality and possibly clinically appropriate omega-3 treatment.

Someone with inherited high Lp(a) requires a different risk-management strategy from someone whose cholesterol is mildly elevated because of a change in dietary habits.

Similarly, broad antioxidant or cellular-energy supplements are not interchangeable with interventions shown to lower atherogenic particle exposure.

The strongest nutritional-support program begins with the lipid problem and its evidence-based management—not with the number of cardiovascular supplements taken.

Explore the Heart, Blood Pressure, Cholesterol & Circulation collection for relevant nutritional-support products.

Can Medication and Natural Cholesterol Support Work Together?

Yes. A comprehensive heart-health approach can include high-quality nutrition, regular activity, appropriate supplements and proven medical treatment.

These interventions do not need to be viewed as competing philosophies.

When Lifestyle Alone May Be Insufficient

People with familial hypercholesterolemia, established atherosclerotic cardiovascular disease or substantially elevated LDL may need medication to achieve appropriate risk reduction.

Other risk factors, including diabetes, chronic kidney disease and inherited Lp(a), can also affect treatment recommendations.

Established LDL-Lowering Treatments

Statins are a major foundation of evidence-based LDL-lowering treatment.

Other therapies, including ezetimibe, PCSK9-targeting agents and additional prescription options, may be appropriate depending on the person's risk, LDL response and treatment tolerability.

The appropriate choice should be made with a qualified healthcare professional.

Do Cholesterol Medications Stop the Body From Needing Cholesterol?

No. Lowering excessive circulating LDL does not mean eliminating cholesterol from the body.

The body continues to use cholesterol for essential cellular functions, while treatment aims to reduce atherosclerotic risk.

Do Not Stop Medication Because of a Supplement

Supplements should not replace prescribed lipid-lowering therapy without appropriate medical review.

Some supplements can also interact with anticoagulants, antiplatelet drugs and other cardiovascular medications.

The goal is to choose interventions that meaningfully reduce risk while maintaining safety and adequate nutrition.

A Practical 14-Step Strategy for Better Cholesterol Health

Step 1 — Understand Your Lipid Panel

Review LDL cholesterol, HDL cholesterol, triglycerides and non-HDL cholesterol rather than looking only at total cholesterol.

Step 2 — Assess Overall Cardiovascular Risk

Consider age, blood pressure, diabetes, kidney disease, smoking, family history and any established cardiovascular disease.

Step 3 — Consider Lp(a) Testing

The 2026 guideline recommends measuring Lp(a) at least once in adulthood to identify inherited risk.

Step 4 — Use ApoB When It Adds Value

Consider ApoB when elevated triglycerides, diabetes or differences between lipid measurements make particle-related risk less clear.

Step 5 — Improve the Overall Dietary Pattern

Choose a sustainable Mediterranean-style or DASH-style approach emphasizing plant-rich foods and appropriate protein sources.

Step 6 — Replace Some Saturated Fat

Use suitable unsaturated fats in place of frequently consumed saturated-fat-rich foods.

Step 7 — Increase Viscous Soluble Fiber

Include oats, barley, legumes and, when appropriate, psyllium or other proven viscous fiber sources.

Step 8 — Consider Plant Sterols When Appropriate

Use plant sterols or stanols as a targeted additional intervention when LDL reduction is the goal and their use is appropriate.

Step 9 — Address Triglycerides Separately

If triglycerides are elevated, review blood sugar, alcohol intake, dietary patterns, medications and other contributing factors.

Step 10 — Build Consistent Movement

Include appropriate aerobic activity and resistance training to support cardiovascular fitness and metabolic health.

Step 11 — Protect Sleep and Avoid Nicotine

Support adequate sleep and address smoking or other nicotine exposure as important cardiovascular risk factors.

Step 12 — Choose Supplements by Purpose

Select a product according to its actual ingredients, intended function and clinical evidence rather than a broad heart-health claim.

Step 13 — Recheck Relevant Markers

Repeat lipid measurements at an appropriate interval after meaningful dietary or treatment changes.

Clinical follow-up helps determine whether LDL and other risk factors are improving enough.

Step 14 — Escalate Treatment When Risk Remains High

If LDL, ApoB or overall cardiovascular risk remains significantly elevated, additional medical treatment may provide greater protection than increasing the supplement routine.

When Should High Cholesterol Receive Medical Evaluation?

High cholesterol often causes no symptoms, but certain lipid patterns and risk factors justify timely assessment.

Seek appropriate medical advice when:

• LDL cholesterol is markedly elevated, particularly at or above 190 mg/dL.
• There is a family history of premature heart attack or stroke.
• Familial hypercholesterolemia is suspected.
• Lp(a) is elevated.
• Triglycerides are substantially elevated, especially 500 mg/dL or higher.
• Diabetes or chronic kidney disease increases cardiovascular risk.
• Coronary artery disease, stroke or peripheral artery disease is already present.
• Cholesterol remains above an appropriate treatment goal despite strong lifestyle measures.
• Medication side effects or supplement interactions are a concern.

Extremely high triglycerides require prompt evaluation because of pancreatitis risk. Severe persistent abdominal pain, particularly with vomiting, may indicate pancreatitis and requires urgent medical attention.

Chest pressure, severe shortness of breath, sudden weakness or numbness, difficulty speaking and other possible heart-attack or stroke symptoms require immediate emergency care regardless of cholesterol levels.

Frequently Asked Questions About Cholesterol and Heart Health

Is cholesterol bad for you?

No. Cholesterol is essential for normal cell membranes, hormone production and bile-acid synthesis. Cardiovascular risk increases when excessive numbers of atherogenic lipoprotein particles circulate over time.

Does the body need cholesterol?

Yes. The body needs cholesterol for several essential functions and can synthesize the cholesterol it requires.

Why is LDL called bad cholesterol?

LDL particles can enter artery walls and contribute to atherosclerotic plaque when exposure is excessive. The term bad describes cardiovascular risk rather than suggesting LDL has no normal physiological role.

Is HDL always good?

No. HDL participates in cholesterol transport, but simply raising HDL cholesterol has not consistently reduced cardiovascular events.

Can high cholesterol cause heart disease?

Yes. Prolonged exposure to elevated LDL and other atherogenic lipoproteins contributes causally to atherosclerotic cardiovascular disease.

Can you have high cholesterol without symptoms?

Yes. Elevated LDL and other lipid abnormalities commonly develop without noticeable symptoms. Blood testing is necessary to identify them.

Is total cholesterol enough to understand heart risk?

No. LDL, HDL, triglycerides, non-HDL cholesterol and selected additional measurements can provide a more informative picture.

What is the difference between LDL and ApoB?

LDL cholesterol measures cholesterol carried within LDL particles, while ApoB provides information about the number of major atherogenic lipoprotein particles.

What does non-HDL cholesterol mean?

Non-HDL cholesterol is total cholesterol minus HDL cholesterol. It includes cholesterol in LDL and other potentially atherogenic particles.

What is lipoprotein(a)?

Lp(a) is a largely inherited lipoprotein associated with increased atherosclerotic cardiovascular risk. The 2026 guideline recommends measuring it at least once in adulthood.

Does eating cholesterol directly clog arteries?

No. Atherosclerosis involves circulating lipoproteins entering and becoming retained within artery walls. Dietary cholesterol can influence blood lipids, but the relationship is more complex than cholesterol from food directly sticking to arteries.

Is saturated fat worse than dietary cholesterol?

For most people, improving saturated fat intake and the overall dietary pattern is a more important cardiovascular priority than focusing exclusively on dietary cholesterol.

Can eggs be included in a heart-healthy diet?

Yes, for many people. The appropriate amount depends on overall diet quality, saturated fat intake, individual lipid response and cardiovascular risk.

Can plant foods lower LDL?

Certain plant foods, especially those providing viscous soluble fiber and unsaturated fats, can help lower LDL as part of an appropriate dietary pattern.

Does psyllium lower cholesterol?

Yes. Psyllium is a viscous soluble fiber with clinical evidence for modest LDL reduction when consumed consistently in appropriate amounts.

Do omega-3 supplements lower LDL cholesterol?

Omega-3 supplements are primarily relevant to triglyceride reduction. They are not the main evidence-based nutritional treatment for lowering LDL, and some DHA-containing preparations may raise LDL in certain circumstances.

Can CoQ10 lower LDL?

CoQ10 participates in cellular energy metabolism but has not been established as a reliable LDL-lowering treatment.

Does vitamin E remove plaque from arteries?

There is insufficient clinical evidence that ordinary vitamin E or tocotrienol supplements remove established atherosclerotic plaque or prevent cardiovascular events.

Can high cholesterol be caused by genetics?

Yes. Familial hypercholesterolemia and other inherited factors can produce elevated LDL or increased cardiovascular risk even when dietary and lifestyle habits are favorable.

Can lowering LDL reduce heart-attack risk?

Yes. Effective LDL-lowering treatment reduces atherosclerotic cardiovascular events in appropriate populations. The degree of benefit depends on starting risk, the amount of LDL reduction and other factors.

Can natural supplements replace cholesterol medication?

Not when medication is medically indicated. Some nutritional interventions modestly improve LDL, but supplements are not interchangeable with proven therapies for high-risk cardiovascular disease.

A Better Definition of Cholesterol Support

Cholesterol is not a toxin that the body needs to eliminate.

It is an essential substance involved in cell membranes, steroid hormone production, bile-acid synthesis and many other physiological functions.

The cardiovascular issue is how cholesterol and other lipids travel through the bloodstream and how long artery walls remain exposed to excessive numbers of atherogenic particles.

LDL cholesterol provides important information, but non-HDL cholesterol and ApoB may reveal additional lipoprotein-related risk. Lp(a) can identify inherited susceptibility that ordinary lifestyle changes may not substantially alter.

Triglycerides also matter, particularly when insulin resistance, diabetes or other metabolic disorders are present.

The liver plays a central role in cholesterol synthesis, transport and clearance, but high LDL should not automatically be attributed to liver congestion, gallbladder dysfunction or inadequate stomach acid.

Nutrition can influence cholesterol through dietary fat quality, viscous soluble fiber, plant sterols and overall food choices. Physical activity, weight management when relevant, adequate sleep and avoidance of nicotine help address broader cardiovascular risk.

Purposeful supplements may fit within this framework when selected for a specific nutritional need, but broad antioxidant or botanical activity does not guarantee LDL reduction or plaque reversal.

For people with familial hypercholesterolemia, established cardiovascular disease or significantly elevated risk, effective medication may provide substantial additional protection.

The goal is not to eliminate a substance the body needs. It is to reduce the harmful consequences of excessive atherogenic lipoprotein exposure while supporting the overall cardiovascular system.

A better definition of cholesterol support is maintaining healthy lipid metabolism, reducing unnecessary exposure to plaque-forming particles, improving metabolic and vascular health, and using the combination of nutrition, lifestyle, targeted support and treatment that best lowers long-term cardiovascular risk.

For a broader discussion of blood pressure, cholesterol, circulation and long-term cardiovascular risk, continue reading our pillar guide: Heart Health Explained: Blood Pressure, Cholesterol, Circulation and Cardiovascular Risk.

References and Further Reading

1. American Heart Association and American College of Cardiology. 2026 Guideline on the Management of Dyslipidemia — Top Things to Know. Current guidance on LDL, non-HDL cholesterol, ApoB, Lp(a), cardiovascular risk and lipid-lowering treatment.
2. American Heart Association and American College of Cardiology. 2026 Guideline on the Management of Dyslipidemia. Full clinical guideline published in Circulation covering dyslipidemia assessment, prevention and treatment.
3. American Heart Association. What Is Cholesterol?. Reviews cholesterol's essential functions, sources and relationship to cardiovascular health.
4. American Heart Association. Understanding Cholesterol and Lipids. Explains LDL, HDL, triglycerides and Lp(a).
5. American Heart Association. 2026 Dietary Guidance to Improve Cardiovascular Health. Current recommendations for dietary patterns, saturated fat, dietary cholesterol and cardiovascular prevention.
6. American Heart Association. Saturated Fats. Explains the relationship between saturated fat intake, LDL cholesterol and healthier fat substitutions.
7. National Heart, Lung, and Blood Institute. Atherosclerosis. Reviews plaque development and cardiovascular complications.
8. National Center for Complementary and Integrative Health. High Cholesterol and Natural Products. Evidence and safety review covering plant sterols, garlic, fiber-related products and red yeast rice.
9. National Center for Complementary and Integrative Health. High Cholesterol and Dietary Supplements. Practical guidance on evidence-supported and potentially hazardous supplement approaches.
10. National Institutes of Health Office of Dietary Supplements. Omega-3 Fatty Acids — Health Professional Fact Sheet. Reviews triglyceride reduction, cardiovascular outcomes and omega-3 supplement safety.
11. National Center for Complementary and Integrative Health. Coenzyme Q10. Reviews physiological functions, clinical evidence and medication interactions.
12. American Heart Association. Life's Essential 8. Framework for nutrition, physical activity, blood lipids, blood sugar, blood pressure, sleep, weight and nicotine avoidance.
13. Total Health Secrets. Deltanol. Current annatto-derived tocotrienol ingredient information and product positioning.
14. Total Health Secrets. Cardio-ND. Current fermented botanical cardiovascular-support formula.
15. Total Health Secrets. CoQ-10. Current ubiquinone formulation and cellular-energy nutritional positioning.
16. Total Health Secrets. Galactan. Current arabinogalactan fiber content and digestive-support positioning.
17. Total Health Secrets. Premier Greens Powder. Current organic plant-derived nutritional ingredients.

Educational Disclaimer: This article provides general educational information and does not replace individualized medical advice, diagnosis or treatment. Cholesterol and other lipid measurements must be interpreted in the context of cardiovascular history, age, genetics, blood pressure, diabetes, kidney function, smoking status, medications and other risk factors. Dietary supplements may interact with cholesterol-lowering medicines, anticoagulants, antiplatelet drugs and other treatments. Red yeast rice products may contain a statin-like compound and have additional safety and quality concerns. Do not stop prescribed lipid-lowering medication because dietary changes or supplements have been added. Markedly elevated LDL cholesterol, severe hypertriglyceridemia, suspected familial hypercholesterolemia or established cardiovascular disease warrants appropriate medical evaluation. Chest pain, sudden breathlessness, weakness, speech difficulty or other possible heart-attack or stroke symptoms require immediate emergency medical care.